Informe INCA 302
| dc.Type | Article | pt_BR |
| dc.contributor.author | Instituto Nacional de Câncer José Alencar Gomes da Silva | |
| dc.contributor.author | Instituto Nacional de Câncer (Brasil) | |
| dc.contributor.author | INCA | |
| dc.date.accessioned | 2022-07-19T17:15:17Z | |
| dc.date.available | 2022-07-19T17:15:17Z | |
| dc.date.issued | 2012-07 | |
| dc.identifier.uri | http://sr-vmlxaph03:8080/jspui/handle/123456789/9327 | |
| dc.publisher | INCA | pt_BR |
| dc.subject | Laboratórios | pt_BR |
| dc.subject | Laboratories | pt_BR |
| dc.subject | Tratamento Farmacológico | pt_BR |
| dc.subject | Drug Therapy | pt_BR |
| dc.subject | Quimioterapia | pt_BR |
| dc.title | Informe INCA 302 | pt_BR |
| dc.title.alternative | Informe INCA 302 | pt_BR |